Posted by Michael Wonder on 06 Jul 2022
FDA authorises pharmacists to prescribe Paxlovid with certain limitations
6 July 2022 - New prescribing authority could improve access for some patients at high risk for severe COVID-19.
Today, the U.S. FDA revised the emergency use authorisation for Paxlovid (nirmatrelvir and ritonavir), to authorise state licensed pharmacists to prescribe Paxlovid to eligible patients, with certain limitations to ensure appropriate patient assessment and prescribing of Paxlovid.
